THU0164 Risk of serious infections in reumatoid arthritis and other chronic inflammatory immune-mediated diseases treated with TNF antagonists or rituximab:
Cobo-Ibáñez, T., Descalzo, M.A., Muñoz-Fernández, S., Loza, E., Carmona, L., Gόmez-Reino, J.J.Volume:
71
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2012-eular.2129
Date:
June, 2013
File:
PDF, 53 KB
english, 2013